GlassScriptPhysician profile
Bryan J Blonder
NPI 1487624540
$35,700.59
in general payments reported to CMS, 2019-2025
42 companies · $421 in 2025
The $421 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,831 · 2020: $5,427 · 2021: $13K · 2022: $5,936 · 2023: $864 · 2024: $3,324 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,750 · Food and Beverage: $1,859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,750.00 |
| Food and Beverage | $1,859.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $15,106.18 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $10,662.33 | 2019-2021 | |
| Caldera Medical, INC | $4,368.94 | 2019-2024 | Desara |
| Abbvie INC. | $1,383.18 | 2019-2024 | Lo Loestrin Fe |
| Lupin INC. | $530.32 | 2019-2021 | |
| Stryker Corporation | $500.00 | 2021 | |
| Exeltis, USA INC. | $281.64 | 2019-2025 | Slynd, Solosec |
| Millicent US INC | $254.10 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Mayne Pharma Commercial LLC | $235.32 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $214.98 | 2023-2025 | Myfembree |
| Bausch Health US, LLC | $206.01 | 2020-2021 | |
| Pfizer INC. | $186.15 | 2019-2024 | |
| Therapeuticsmd, INC. | $183.99 | 2019-2020 | |
| Radius Health, INC. | $147.50 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $124.91 | 2019 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Blonder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.